We have reported a robust anti-metastatic effect of BMP4 signalling in pre-clinical models of breast cancer [7, 8] and highlighted the potential of activating BMP4 signalling as a viable therapeutic approach to treat metastatic breast cancer. This evidence concerns the gene BMP4 and breast carcinoma.